[Federal Register Volume 67, Number 132 (Wednesday, July 10, 2002)]
[Notices]
[Pages 45763-45764]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 02-17206]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Application

    Pursuant to Sec. 1301.33(a) of Title 21 of the Code of Federal 
Regulations (CFR), this is notice that on January 15, 2002, Ansys 
Technologies, Inc., 25200 Commercentre Drive, Lake Forest, California 
92630, made application by renewal to the Drug Enforcement 
Administration (DEA) for registration as

[[Page 45764]]

a bulk manufacturer of the basic classes of controlled substances 
listed below:

 
------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Phencyclidine (7471).......................  II
1-Piperidinocyclohexane-carbonitrile (8603)  II
Benzoylecgonine (9180).....................  II
------------------------------------------------------------------------

    The firm plans to manufacture the listed controlled substances to 
produce standards and controls for in-vitro diagnostic drug testing 
systems.
    Any other such applicant and any person who is presently registered 
with DEA to manufacture such substances may file comments or objections 
to the issuance of the proposed registration.
    Any such comments or objections may be addressed, in quintuplicate, 
to the Deputy Assistant Administrator, Office of Diversion Control, 
Drug Enforcement Administration, United States Department of Justice, 
Washington, DC 20537, Attention: DEA Federal Register Representative 
(CCR), and must be filed no later than September 9, 2002.

    Dated: June 18, 2002.
Laura M. Nagel,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 02-17206 Filed 7-9-02; 8:45 am]
BILLING CODE 4410-09-M